The MRDR supports Rare Disease Day 2023 😊
The MRDR has reached 5800 registered patients!
Paper on the second revision of the International Staging System (R2-ISS) accepted for publication!
The MRDR was recently represented at the 4th National Myeloma Workshop.
Thank you to all attendees for contributing to a successful MRDR Interest Group breakfast at Blood 2022!
The MRDR was well-represented at Blood 2022!
Two MRDR presentations at the International Myeloma Society Annual meeting in LA!
Paper on on early mortality in multiple myeloma accepted for publication!
Khaili Chai's poster at EHA Congress
MRDR paper on Māori and Pacific Peoples with MM in New Zealand accepted for publication!